Oncolytics Biotech Inc. has announced preliminary results from its U.S. Phase 2 clinical trial in patients with metastatic melanoma using intravenous administration of REOLYSIN® in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results